Abstract: The present disclosure provides the use of Lactobacillus paracasei subsp. paracasei K56 in enhancing resistance of the intestinal tract to bacterial infection and improving intestinal immunity. Particularly, the present disclosure provides the use of a Lactobacillus paracasei subsp. paracasei in the preparation of a composition for improving intestinal immunity, wherein the Lactobacillus paracasei subsp. paracasei has a deposit number of CGMCC 15139 or DSM 27447. The present inventors have discovered that this bacteria strain alone can significantly improve the resistance of the intestinal tract to bacterial infection, combat invasion by pathogenic bacteria in the intestinal system, maintain the intestinal barrier function, and/or prevent diarrhea caused by pathogenic bacteria.

Abstract: The present disclosure provides the use of Lactobacillus paracasei ET-22 in enhancing resistance of the intestinal tract to bacterial infection and improving intestinal immunity. Particularly, the present disclosure provides the use of a Lactobacillus paracasei in the preparation of a composition for improving intestinal immunity, wherein the Lactobacillus paracasei has a deposit number of CGMCC 15077. The present inventors have discovered that this bacteria strain alone can significantly improve the resistance of the intestinal tract to bacterial infection, combat invasion by pathogenic bacteria in the intestinal system, maintain the intestinal barrier function, and/or prevent diarrhea caused by pathogenic bacteria.

Abstract: The present disclosure provides a composition comprising Bifidobacterium lactis and human milk oligosaccharides (HMOs) and use thereof. The composition is capable of effectively enhancing resistance of an organism to Staphylococcus aureus infection, improving innate immunity of an organism, and/or anti-aging, and can be added to various health foods and healthcare foods.

Abstract: The present invention relates to the field of food and pharmaceutical products, and specifically to human milk oligosaccharide for improving resistance of organism against Staphylococcus aureus infection. In particular, the present invention relates to use of human milk oligosaccharide in preparation of a nutritional composition or medicament for prevention and/or treatment of diseases associated with Staphylococcus aureus infection in individuals, or for alleviation of discomfort associated with Staphylococcus aureus infection, or for improvement of an individual's resistance against Staphylococcus aureus infection, or for improvement of an individual's innate immunity and/or anti-aging.

Abstract: The invention relates to a method for making cheese wherein cheese is salted with a salting agent comprising milk minerals and NaCl or a mixture thereof. The invention also relates to ripened cheese having a ratio of K/Na of 0.39 to 4.0 and a K content of more than 0.08%.

Abstract: The invention relates to a method for making cheese wherein cheese is salted with a salting agent comprising milk minerals and NaCl or a mixture thereof. The invention also relates to ripened cheese having a ratio of K/Na of 0.39 to 4.0 and a K content of more than 0.08%.

Abstract: A system for monitoring electric current in a network comprising at least one electrical fuse including a protective body, and at least one interrogating device arranged to interrogate at least one current sensing unit. The invention also concerns a method to monitor electric current in a network, including the steps of: determining a current in the electrical fuse, for example, via a voltage drop measurement across a fusible resistor in the electrical fuse; transmitting current determinations from the current sensing unit, for example, to a central management device; and processing received data from the at least one current sensing unit.

Abstract: The invention relates to a method for making cheese wherein cheese is salted with a salting agent comprising milk minerals and NaCl or a mixture thereof. The invention also relates to ripened cheese having a ratio of K/Na of 0.39 to 4.0 and a K content of more than 0.08%.

Abstract: A method and pre-processor for processing a MCPM signal including a phase multiplier for multiplying a MCPM signal by a scaling factor. The pre-processor also includes a frequency shifter for shifting the scaled MCPM signal to create a frequency offset. The pre-processing allows a MDPSK demodulator to demodulate the received MCPM signal. This Abstract is provided to comply with rules requiring an Abstract that allows a searcher or other reader to quickly ascertain subject matter of the technical disclosure. This Abstract is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).

Abstract: A system for estimating the modulation index and frequency offset of a CPM signal. An estimator filters the received signal and utilizes a training sequence to determine the modulation index and frequency offset of the CPM signal. The estimator can also include a post-processing step to eliminate all or part of a bias that might be created by the estimator.

Abstract: A method and apparatus for phase-domain semi-coherent demodulator including a receiver for receiving at least a phase component of an input signal. The phase domain semi-coherent demodulator may include a decision unit for forming a decision based on a delayed reference signal and the phase component of the input signal. In addition the phase domain semi-coherent demodulator may include a phase sum adder for subtracting the decision from the phase component of the input signal to form a rotated input phase, a second phase sum adder for subtracting the delayed reference signal from the rotated input phase to form a resulting signal, and a scaler for scaling the resulting signal to form an update signal. A third phase sum adder adds the update signal to the delayed reference signal to form a reference signal.

Abstract: A method and pre-processor for processing a MCPM signal including a phase multiplier for multiplying a MCPM signal by a scaling factor. The pre-processor also includes a frequency shifter for shifting the scaled MCPM signal to create a frequency offset. The pre-processing allows a MDPSK demodulator to demodulate the received MCPM signal. This Abstract is provided to comply with rules requiring an Abstract that allows a searcher or other reader to quickly ascertain subject matter of the technical disclosure. This Abstract is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).

Abstract: A system for estimating the modulation index and frequency offset of a CPM signal. An estimator filters the received signal and utilizes a training sequence to determine the modulation index and frequency offset of the CPM signal. The estimator can also include a post-processing step to eliminate all or part of a bias that might be created by the estimator.

Abstract: A method and apparatus for phase-domain semi-coherent demodulator including a receiver for receiving at least a phase component of an input signal. The phase domain semi-coherent demodulator may include a decision unit for forming a decision based on a delayed reference signal and the phase component of the input signal. In addition the phase domain semi-coherent demodulator may include a phase sum adder for subtracting the decision from the phase component of the input signal to form a rotated input phase, a second phase sum adder for subtracting the delayed reference signal from the rotated input phase to form a resulting signal, and a scaler for scaling the resulting signal to form an update signal. A third phase sum adder adds the update signal to the delayed reference signal to form a reference signal.

Abstract: New mixed cultures of two or more micro-organism strains are provided wherein at least one of said micro-organism strains which are comprised in said mixed culture is individually selected on the basis of its ability to perform part of an enzymatic pathway, and said two or more selected micro-organism strains together form a complete pathway towards a desired flavour component. Preferably, the mixed culture is a culture for the production of a fermented product, such as yogurt or cheese or sausage. Said two or more micro-organism strains are preferably co-cultivated. Particular and preferred embodiments are starter cultures for the manufacturing of cheese, comprising a combination of various Lactoccocus strains and a combination of a Brevibacterium strain and a Staphylococcus strain, respectively.

Abstract: The invention relates to methods for increasing and/or prolonging in vivo or in vitro activity of plant growth regulators (PGRs), comprising of locally increasing the concentration of active plant growth regulators in a plant and/or plant part(s) and/or increasing the sensitivity of the plant and/or plant part(s) to the activity of the plant growth regulators. The local increase can for instance take place by administering the PGRs in capsules. The increase in the sensitivity can be brought about by administering elicitors or means which result in the formation of elicitors. By adding both elicitors and (modified, e.g. slow-release) PGRs the induced response can be timed.

Abstract: The invention relates to methods for increasing and/or prolonging in vivo or in vitro activity of plant growth regulators (PGRs), comprising of locally increasing the concentration of active plant growth regulators in a plant and/or plant part(s) and/or increasing the sensitivity of the plant and/or plant part(s) to the activity of the plant growth regulators. The local increase can for instance take place by administering the PGRs in capsules. The increase in the sensitivity can be brought about by administering elicitors or means which result in the formation of elicitors. By adding both elicitors and (modified, e.g. slow-release) PGRs the induced response can be timed.

Abstract: A radio LAN station is provided for receiving information frames including start and end delimiters and user data therebetween. The start and end delimiters include both data symbols and special non-data symbols. The data symbols and non-data symbols being transmitted to the radio LAN station are sent thereto via a spread spectrum signal. The data symbols and the non-data symbols are spread via first and second spreading codes, respectively. The receiving radio LAN station includes first and second correlators which respectively correlate the received spread spectrum signal against the first spreading code to retrieve the data symbols and against the second spreading code to retrieve the non-data symbols. Rectangular representations of the received data and non-data symbols are thus produced and are converted to polar form via appropriate rectangular to polar converters. The polar representations of the data and non-data symbols respectively exhibit a vector length Z and a vector length Z'.